Masashi Takenaka

Fujita Health University, Fujita Health University Hospital

Papers

6

Total Citations

76

H-Index

5

About

Dr. Masashi Takenaka is a leading urologic surgeon and researcher whose work centers on advancing minimally invasive surgical techniques for bladder and kidney cancers, with a particular focus on robot-assisted procedures. His major contributions include pioneering studies on robot-assisted radical cystectomy (RARC) with intracorporeal urinary diversion, where he identified key risk factors for postoperative ileus—a critical complication—and demonstrated comparable long-term oncologic outcomes to open surgery through propensity score-matched analyses. In renal surgery, Dr. Takenaka has systematically compared robot-assisted partial nephrectomy (RAPN) to open approaches, showing superior perioperative outcomes and equivalent long-term functional preservation in Japanese cohorts. He has also innovated in surgical technique, evaluating selective clamping to minimize renal ischemia and introducing novel intraoperative navigation using ultra-high-resolution CT to enhance precision. His work on cystic renal tumors further expands the indications for RAPN. With over 75 citations across his most influential papers, Dr. Takenaka’s research is shaping the evidence base for robotic urologic oncology, offering patients safer, more effective surgical options.

Research Focus

Key Achievements

5
H-Index
6
Papers
76
Total Citations
13
Avg Citations/Paper
🏆 Most Cited Paper
Risk factors for postoperative ileus after robot‐assisted radical cystectomy with intracorporeal urinary diversion
25 citations · 2022
📈 Most Prolific Year: 2022 (4 Papers)
🤝 Key Collaborators: 15
🏛 Institutions: Fujita Health University, Fujita Health University Hospital

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago